Context Bladder cancer (BC) is a significant health problem, and understanding the risk
factors for this disease could improve prevention and early detection. Objective To provide a …

Context Bladder cancer (BC) is common worldwide and poses a significant public health
challenge. External risk factors and the wider exposome (totality of exposure from external …

Patient risk stratification is essential for optimal management of patients with bladder cancer.
Risk status determines the application and timing of therapeutic interventions such as repeat …

Background Muscle-invasive bladder cancer (MIBC) is a molecularly diverse disease with
heterogeneous clinical outcomes. Several molecular classifications have been proposed …

Background An early report on the molecular subtyping of muscle-invasive bladder cancer
(MIBC) by gene expression suggested that response to neoadjuvant chemotherapy (NAC) …

Purpose Clinicopathologic features and biochemical recurrence are sensitive, but not
specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a …

Patterns of Relapse in Patients With Clinical Stage I Testicular Cancer Managed With Active
Surveillance Page 1 Patterns of Relapse in Patients With Clinical Stage I Testicular Cancer …

Purpose: Patients with locally advanced prostate cancer after radical prostatectomy are
candidates for secondary therapy. However, this higher risk population is heterogeneous …

Background The efficacy of neoadjuvant chemotherapy (NAC) for muscle-invasive bladder
cancer (BCa) was established primarily with methotrexate, vinblastine, doxorubicin, and …

Context This review focuses on risk assessment and prediction tools for bladder cancer
(BCa). Objective To review the current knowledge on risk assessment and prediction tools to …